Acute Respiratory Distress Syndrome Market
                     Acute 
Respiratory 
Distress 
Syndrome 
Market To 
Reach USD 
934.8 Million 
By 2026
Market 
Summary
Market Size – USD 583.8 Million in 2018, Market Growth - CAGR of 6.0% for 
the year 2026, Market trends – Increasing lung injuries due to car accidents 
with various chronic diseases such as pulmonary or systemic infection, 
neurological conditions, among others.
According to the analysis of Reports and Data, the global acute respiratory distress syndrome market was 
valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2026, at a CAGR 
of 6.0%. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung 
inflammation. Due to which there is a problem with the proper delivery of the oxygen to the different body 
organs, which at the end impact the appropriate functioning of the parts. Various causes are included with 
the ARDS, such as sepsis, trauma, pneumonia, and others. The primary treatment for the ARDS involves 
mechanical ventilation, which is delivered through a rigid tube that enters the oral cavity and is secured in 
the airway.
Market 
Summary
The Global Acute Respiratory Distress Syndrome Market Report is an extensive and comprehensive 
document comprising details on business strategies, qualitative and quantitative analysis of the market on 
global and regional levels. The report offers a detailed analysis of the key segments of the Global Acute 
Respiratory Distress Syndrome Market along with an in-depth analysis of drivers, restraints, challenges, 
trends, growth prospects, opportunities. The report strives to offer a deeper understanding of the Acute 
Respiratory Distress Syndrome industry by offering an extensive overview of the competitive landscape and 
regional segmentation. 
The report assesses the impact of various market factors on the growth of the Acute Respiratory Distress 
Syndrome market in key regions and across key segments. The report considers the COVID-19 pandemic as a 
key influencing factor. It offers a detailed insight into the impact of COVID-19 on the industry at a regional 
level and industry level. The report also covers the developments and government regulations related to 
COVID-19. The report further analyzes the current and future impact of COVID-19 on the global market and 
provides an insight into the situation post-COVID-19. Furthermore, the report provides a comprehensive 
analysis of the impact of the COVID-19 crisis on the market. 
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2089
Market 
Summary
Key market players include
Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, 
Athersys, GlaxoSmithKline, Altor Bioscience, BPL Technologies, and Mondobiotech
Top Players Covered in the Report Include:
Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, 
Athersys, GlaxoSmithKline, Altor Bioscience, BPL Technologies, and Mondobiotech
Severity Outlook (Revenue in USD Million; Volume in Tons, 2017–2027)
• Mild
• Moderate
• Severe
Treatment Outlook (Revenue in USD Million; Volume in Tons, 2017–2027)
• Fibro Proliferate
• Exudative Stage
• Resolution Stage
• Recovery Stage
To know more about the report, visit @ https://
www.reportsanddata.com/report-detail/acute-respiratory-distress-syndrome-ards-market
Market 
Summary
Further key findings from the report suggest
Sales Channel Outlook (Revenue in USD Million; 2017–2027)
• Direct sales
• Channel sales
End-User (Revenue in USD Million; 2017–2027)
• Hospitals
• Clinics
• Ambulatory Service Centers
• Others
Regional Outlook (Revenue, USD Million; 2017-2027)
North America
U.S
Canada
Mexico
Europe
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2089
 
About 
US Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, 
and consulting services. Our solutions purely focus on your purpose to 
locate, target and analyze consumer behavior shifts across demographics, 
across industries and help client’s make a smarter business decision. 
We offer market intelligence studies ensuring relevant and fact-based 
research across a multiple industries including Healthcare, Technology, 
Chemicals, Power, and Energy. We consistently update our research 
offerings to ensure our clients are aware about the latest trends existent in 
the market. Reports and Data has a strong base of experienced analysts 
from varied areas of expertise.
Contact US
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]